Dyadic International, Inc. (DYAI)
0.3401
-0.03
(-7.25%)
USD |
NASDAQ |
Nov 05, 16:00
Dyadic International Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2026 | 21.43 |
| March 27, 2026 | 19.93 |
| March 26, 2026 | 20.59 |
| March 25, 2026 | 25.62 |
| March 24, 2026 | 24.79 |
| March 23, 2026 | 25.25 |
| March 20, 2026 | 27.60 |
| March 19, 2026 | 23.44 |
| March 18, 2026 | 22.90 |
| March 17, 2026 | 23.55 |
| March 16, 2026 | 23.76 |
| March 13, 2026 | 22.31 |
| March 12, 2026 | 22.44 |
| March 11, 2026 | 23.52 |
| March 10, 2026 | 24.37 |
| March 09, 2026 | 23.49 |
| March 06, 2026 | 22.54 |
| March 05, 2026 | 22.32 |
| March 04, 2026 | 24.19 |
| March 03, 2026 | 23.17 |
| March 02, 2026 | 22.49 |
| February 27, 2026 | 22.87 |
| February 26, 2026 | 22.91 |
| February 25, 2026 | 24.65 |
| February 24, 2026 | 24.02 |
| Date | Value |
|---|---|
| February 23, 2026 | 23.49 |
| February 20, 2026 | 23.34 |
| February 19, 2026 | 23.54 |
| February 18, 2026 | 23.82 |
| February 17, 2026 | 23.63 |
| February 13, 2026 | 24.37 |
| February 12, 2026 | 24.22 |
| February 11, 2026 | 23.36 |
| February 10, 2026 | 24.45 |
| February 09, 2026 | 24.46 |
| February 06, 2026 | 25.00 |
| February 05, 2026 | 24.94 |
| February 04, 2026 | 24.87 |
| February 03, 2026 | 24.96 |
| February 02, 2026 | 25.28 |
| January 30, 2026 | 25.57 |
| January 29, 2026 | 26.57 |
| January 28, 2026 | 25.81 |
| January 27, 2026 | 25.96 |
| January 26, 2026 | 25.80 |
| January 23, 2026 | 26.42 |
| January 22, 2026 | 26.78 |
| January 21, 2026 | 26.08 |
| January 20, 2026 | 26.00 |
| January 16, 2026 | 25.55 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.28 |
| Anika Therapeutics, Inc. | 1.652 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.9579 |
Price to Book Value Related Metrics
| PS Ratio | 3.210 |
| PEG Ratio | -0.1133 |
| Price | 0.3401 |
| Earnings Yield | -62.51% |
| Market Cap | 12.39M |
| PEGY Ratio | -0.1133 |